PMID- 22069271 OWN - NLM STAT- MEDLINE DCOM- 20120325 LR - 20221207 IS - 1520-7560 (Electronic) IS - 1520-7552 (Linking) VI - 27 IP - 8 DP - 2011 Nov TI - Analysis of the HLA and non-HLA susceptibility loci in Japanese type 1 diabetes. PG - 844-8 LID - 10.1002/dmrr.1234 [doi] AB - BACKGROUND: We previously reported the associations of human leukocyte antigen (HLA) (DRB1 and DQB1), INS, CTLA4, IL2RA, ERBB3 and CLEC16A with Japanese type 1 diabetes (T1D). In this study, we jointly analysed these loci in addition to IFIH1 and IL7R. METHODS: A maximum of 790 T1D patients and 953 control subjects were analysed. HLA was determined by sequencing-based typing. Seven non-HLA single nucleotide polymorphisms were genotyped using TaqMan assay. RESULTS: HLA DRB1*0405, DRB1*0901 and DRB1*0802-DQB1*0302 haplotypes were positively associated with T1D, while the DRB1*15 haplotypes were negatively associated. Non-HLA single nucleotide polymorphisms, INS, IL2RA, ERBB3, CLEC16A and IL7R were associated with T1D. By a prediction model using the HLA loci alone (HLA model) or the non-HLA loci alone (non-HLA model), it was revealed that the cumulative effect of the non-HLA model was much weaker than that of the HLA model (average increase in odds ratio: 1.17 versus 3.14). Furthermore, the area under the receiver operating characteristic curve of the non-HLA model was also much smaller than that of the HLA model (0.65 versus 0.81, p<10(-11)). Finally, a patient-only analysis revealed the susceptible HLA haplotypes and the risk allele of INS to be negatively associated with slower onset of the disease. In addition, the DRB1*0901 haplotype and the risk alleles of ERBB3, CLEC16A and CTLA4 were positively associated with the co-occurrence of thyroid autoimmunity. CONCLUSIONS: Although several non-HLA susceptibility genes in Japanese were confirmed trans-racially and appear to contribute to the heterogeneity of the clinical phenotypes, the cumulative effect on the ability to predict the development of T1D was weak. CI - Copyright (c) 2011 John Wiley & Sons, Ltd. FAU - Yamashita, Hisakuni AU - Yamashita H AD - Department of Endocrinology and Diabetes, Faculty of Medicine, Saitama Medical University, Saitama, Japan. FAU - Awata, Takuya AU - Awata T FAU - Kawasaki, Eiji AU - Kawasaki E FAU - Ikegami, Hiroshi AU - Ikegami H FAU - Tanaka, Shoichiro AU - Tanaka S FAU - Maruyama, Taro AU - Maruyama T FAU - Shimada, Akira AU - Shimada A FAU - Nakanishi, Koji AU - Nakanishi K FAU - Takahashi, Kazuma AU - Takahashi K FAU - Kobayashi, Tetsuro AU - Kobayashi T FAU - Kawabata, Yumiko AU - Kawabata Y FAU - Miyashita, Yumi AU - Miyashita Y FAU - Kurihara, Susumu AU - Kurihara S FAU - Morita-Ohkubo, Tomoko AU - Morita-Ohkubo T FAU - Katayama, Shigehiro AU - Katayama S CN - Japanese Study Group on Type 1 Diabetes Genetics LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Diabetes Metab Res Rev JT - Diabetes/metabolism research and reviews JID - 100883450 RN - 0 (Autoantibodies) RN - 0 (CLEC16A protein, human) RN - 0 (HLA-DR Antigens) RN - 0 (HLA-DRB1 Chains) RN - 0 (Histocompatibility Antigens Class I) RN - 0 (Histocompatibility Antigens Class II) RN - 0 (IL2RA protein, human) RN - 0 (Insulin) RN - 0 (Interleukin-2 Receptor alpha Subunit) RN - 0 (Lectins, C-Type) RN - 0 (Monosaccharide Transport Proteins) SB - IM MH - Age of Onset MH - Asian People/genetics MH - Autoantibodies/analysis MH - Diabetes Mellitus, Type 1/*genetics MH - Female MH - Genetic Predisposition to Disease/genetics MH - HLA-DR Antigens/genetics MH - HLA-DRB1 Chains/genetics MH - Haplotypes MH - Histocompatibility Antigens Class I/genetics MH - Histocompatibility Antigens Class II/*genetics MH - Humans MH - Insulin/genetics MH - Interleukin-2 Receptor alpha Subunit/genetics MH - Lectins, C-Type/genetics MH - Male MH - Monosaccharide Transport Proteins/genetics MH - Polymorphism, Single Nucleotide MH - Thyroid Gland/immunology FIR - Awata, Takuya IR - Awata T FIR - Ikegami, Hiroshi IR - Ikegami H FIR - Kawasaki, Eiji IR - Kawasaki E FIR - Kobayashi, Tetsuro IR - Kobayashi T FIR - Maruyama, Taro IR - Maruyama T FIR - Nakanishi, Koji IR - Nakanishi K FIR - Akira IR - Akira FIR - Shimada IR - Shimada FIR - Takahashi, Kazuma IR - Takahashi K EDAT- 2011/11/10 06:00 MHDA- 2012/03/27 06:00 CRDT- 2011/11/10 06:00 PHST- 2011/11/10 06:00 [entrez] PHST- 2011/11/10 06:00 [pubmed] PHST- 2012/03/27 06:00 [medline] AID - 10.1002/dmrr.1234 [doi] PST - ppublish SO - Diabetes Metab Res Rev. 2011 Nov;27(8):844-8. doi: 10.1002/dmrr.1234.